Recent insights into the immunopathogenesis of psoriasis provide new therapeutic opportunities
Open accessThe DOI matches its Crossref record; 110 of the 110 references it cites were found in a registry or an index.
Abstract
Chronic and excessive inflammation in skin and joints causes significant morbidity in psoriasis patients. As a prevalent T lymphocyte-mediated disorder, psoriasis, as well as the side effects associated with its treatment, affects patients globally. In this review, recent progress is discussed in the areas of genetics, the immunological synapse, the untangling of the cytokine web and signaling pathways, xenotransplantation models, and the growing use of selectively targeted therapies. Since psoriasis is currently incurable, new management strategies are proposed to replace previous serendipitous approaches. Such strategic transition from serendipity to the use of novel selective agents aimed at defined targets in psoriatic lesions is moving rapidly from research benches to the bedsides of patients with this chronic and debilitating disease
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The development of psoriatic plaques is accompanied by activation of CD4 + T cells and other immune cells, which provide a plethora of cytokines and chemokines, including TNF and IFNγ 136”
From Inside and out: the activities of senescence in cancer (2014) · cites this paper as [136]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease
Hugot, J.-P., Chamaillard, M., Zouali, H., Lesage, S., Cézard, J.-P., Belaiche, J., Almer, S., Tysk, C., O'Morain, C. A., Gassull, M., et al. (2001) · Nature · doi:10.1038/35079107 · Cited by 5,591
A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease
Ogura, Y., Bonen, D. K., Inohara, N., Nicolae, D. L., Chen, F. F., Ramos, R., Britton, H., Moran, T., Karaliuskas, R., Duerr, R. H., et al. (2001) · Nature · doi:10.1038/35079114 · Cited by 5,030
The Danger Model: A Renewed Sense of Self
Matzinger, P. (2002) · Science · doi:10.1126/science.1071059 · Cited by 4,205 · cited 1×
“in keratinocytes to create a “danger signal” is unclear (51), but several possible molecular events may occur to activate resting dendritic APCs (52), followed by delivery of an antigenic signal”
BackgroundPoints of control in inflammation
Nathan, C. (2002) · Nature · doi:10.1038/nature01320 · Cited by 2,738 · cited 1×
“ic inflammatory diseases, HMGB1 is also considered an important regulator (67).”
BackgroundHuman epithelial cells trigger dendritic cell–mediated allergic inflammation by producing TSLP
Soumelis, V., Reche, P. A., Kanzler, H., Yuan, W., Edward, G., Homey, B., Gilliet, M., Ho, S., Antonenko, S., Lauerma, A., et al. (2002) · Nature Immunology · doi:10.1038/ni805 · Cited by 2,183 · cited 10×
“The successful use of cyclosporin, which acts to block cytokine release, resulted in a paradigm shift away from epidermal keratinocytes to various immunocyte populations including T cell subsets and dendritic APCs.”
BackgroundInfluentialAggarwal, S., Ghilardi, N., Xie, M.-H., de Sauvage, F. J., & Gurney, A. L. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m207577200 · Cited by 1,847
Etanercept in the treatment of psoriatic arthritis and psoriasis: a randomised trial
Mease, P. J., Goffe, B. S., Metz, J., VanderStoep, A., Finck, B., & Burge, D. J. (2000) · The Lancet · doi:10.1016/s0140-6736(00)02530-7 · Cited by 1,446 · cited 1×
“binds TNF-α and improves psoriatic arthritis and skin lesions (93, 94); and onercept, which improves Crohn disease (95).”
Backgroundp38 MAP kinases: key signalling molecules as therapeutic targets for inflammatory diseases
Kumar, S., Boehm, J., & Lee, J. C. (2003) · Nature Reviews Drug Discovery · doi:10.1038/nrd1177 · Cited by 1,197 · cited 1×
“small molecules that can interfere with inflammatory responses mediated by p38 signaling (106), cytokine receptors (107), or rationally designed dominant negative TNF-α variants (108).”
BackgroundEtanercept as Monotherapy in Patients with Psoriasis
Leonardi, C. L., Powers, J. L., Matheson, R. T., Goffe, B. S., Zitnik, R., Wang, A., & Gottlieb, A. B. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa030409 · Cited by 1,175 · cited 1×
“binds TNF-α and improves psoriatic arthritis and skin lesions (93, 94); and onercept, which improves Crohn disease (95).”
BackgroundWeitz-Schmidt, G., Welzenbach, K., Brinkmann, V., Kamata, T., Kallen, J., Bruns, C., Cottens, S., Takada, Y., & Hommel, U. (2001) · Nature Medicine · doi:10.1038/89058 · Cited by 1,041
Cited by
Items 301–400 of 542
Larisch, P., Verwanger, T., Linecker, M., & Krammer, B. E. (2014) · Photodiagnosis and Photodynamic Therapy · doi:10.1016/j.pdpdt.2014.01.002 · Cited by 17
Influence of ustekinumab on body weight of patients with psoriasis: an initial report
Owczarczyk-Saczonek, A. B., Placek, W. J., Rybak‐d′Obyrn, J., & Wygonowska, E. (2014) · Advances in Dermatology and Allergology · doi:10.5114/pdia.2014.40656 · Cited by 14
“Ustekinumab will then have a significant influence on decreasing the production of TNF-α [16], which is of particular importance for metabolism and body mass [7].”
BackgroundPont, M., Giménez‐Arnau, A. M., Pujol, R. M., & Santamaria‐Babí, L. F. (2005) · Journal of Investigative Dermatology · doi:10.1038/sj.jid.5700006 · Cited by 14
“Circulating CLAþ T cells may be involved in the initiation of psoriatic lesions (Nickoloff and Nestle, 2004); however, few studies have compared the phenotype of circulating skin-homing T cells in acute or chronic psoriatic patients.”
Roy, B., Simard, M., Lorthois, I., Bélanger, A., Maheux, M., Duque-Fernandez, A., Rioux, G., Simard, P. F., Deslauriers, M., Masson, L.-C., et al. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-810545-0.00005-x · Cited by 16
Conventional and Unconventional T Cells
Roberts, S. J., & Girardi, M. (2008) · Springer eBooks · doi:10.1007/978-1-84800-165-7_6 · Cited by 19
Langewouters, A. M. G., Bovenschen, H. J., de Jong, E. M. G. J., van Erp, P. E. J., & van de Kerkhof, P. C. M. (2007) · Journal of Dermatological Treatment · doi:10.1080/09546630701395044 · Cited by 14
“The continuously changing insights in the pathogenesis of psoriasis have led to changing therapeutical strategies (1,2).”
BackgroundClinical application of serum biomarkers for detecting and monitoring of chronic plaque psoriasis
Cruz, C. J. G., & Yang, C. (2023) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2023.1196323 · Cited by 17
“6 IFN-γ IFN-γ is a Th1-derived cytokine that mediates downstream processes favoring keratinocyte proliferation, a key occurrence in psoriasis pathogenesis (Nickoloff and Nestle, 2004).”
BackgroundNovel biologic therapies in development targeting IL‐12/IL‐23
Kerkhof, P. V. D. (2010) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/j.1468-3083.2010.03830.x · Cited by 13
Insulin‐like growth factor‐1 in psoriatic plaques treated with PUVA and methotrexate
El-Komy, M. H. M., Amin, I. M., Zidan, A. N., Kadry, D. M., Zeid, O. A., & Shaker, O. G. (2011) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/j.1468-3083.2010.03966.x · Cited by 13
Lin (2009) · International Journal of Molecular Medicine · doi:10.3892/ijmm_00000222 · Cited by 13
Cytotoxic T lymphocytes as a potential brake of keratinocyte proliferation in psoriasis
Vičić, M., Peternel, S., Simonić, E., Tokmadžić, V. S., Massari, D., Brajac, I., Kaštelan, M., & Massari, L. P. (2015) · Medical Hypotheses · doi:10.1016/j.mehy.2015.12.004 · Cited by 13
“It was formerly demonstrated that CD4+ cells have a role in secreting type 1 cytokines such as TNF-alpha, IFNgamma and IL-2, therefore called Th1 cells [8,9].”
BackgroundPsoriasis as an autoimmune disease
Owczarczyk-Saczonek, A. B., & Placek, W. J. (2014) · Dermatology Review · doi:10.5114/dr.2014.45121 · Cited by 17
“Jest to model synapsy immunologicznej w łuszczycy [4, 20].”
MethodAnimal Models of Skin Disorders
Zhang, J. Y. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-809468-6.00015-2 · Cited by 15
Liu, Z., Liu, H., Xu, P., Yin, Q., Wang, Y., Opoku, Y. K., Yang, J., Song, L., Sun, X., Zhang, T., et al. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.09.178 · Cited by 13
Ten-Year Remission of Psoriasis after Allogeneic but Not Autologous Bone Marrow Transplantation
Masszi, T., Farkas, Á., Reményi, P., Lueff, S., Bátai, Á., Kriván, G., Kemény, L. V., DOBOZY, A., & Réti, M. (2005) · Dermatology · doi:10.1159/000089032 · Cited by 13
Th1/Th2 Cytokines in Psoriasis
Jadali, Z., Izad, M. H., Eslami, M., Mansouri, P., Safari, R., Bayatian, P., Mirshafiey, A., & Salehi, A. (2007) · DOAJ (DOAJ: Directory of Open Access Journals) · Cited by 13
Animal models of psoriasis: a brief update
Nestle, F. O., & Nickoloff, B. J. (2006) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/j.1468-3083.2006.01769.x · Cited by 14
Self-citationPapp, K. A., Toth, D. P., & Rosoph, L. (2006) · BMC Dermatology · doi:10.1186/1471-5945-6-9 · Cited by 13
“Patients with the disease present with well-defined, thickened erythematous patches, typically covered with a silver scale, and the condition is characterised by epidermal hyperplasia, dermal angiogenesis, infiltration of activated T-cells and increased cytokine levels [3].”
BackgroundThe immunological and genetic aspects in psoriasis
Sun, L., & Zhang, X. (2014) · Applied Informatics · doi:10.1186/s40535-014-0003-1 · Cited by 14
“The risk of psoriasis is greater in monozygotic twins than in dizygotic twins, confirming the genetic basis of the disease (Nestle et al. 2009).”
BackgroundInfluentialDas, D., Singh, A., Antil, P. S., Sharma, D., Arava, S. K., Khandpur, S., & Sharma, A. (2020) · Immunologic Research · doi:10.1007/s12026-020-09166-0 · Cited by 14
Research Hotspots in Psoriasis: A Bibliometric Study of the Top 100 Most Cited Articles
Tiucă, O. M., Morariu, S. H., Mariean, C. R., Tiucă, R. A., Nicolescu, A. C., & Cotoi, O. S. (2023) · Healthcare · doi:10.3390/healthcare11131849 · Cited by 13
Newer targeted therapies in psoriasis
Khandpur, S., & Bhari, N. (2013) · Indian Journal of Dermatology Venereology and Leprology · doi:10.4103/0378-6323.115532 · Cited by 12
Immune mechanisms of psoriasis. New strategies of biotherapy
Kubanova, A. A., Kubanov, A. A., NIKOLAS, J. F., Puig, L., PRINCE, J., Katunina, O. R., & Znamenskaya, L. F. (2010) · Vestnik dermatologii i venerologii · doi:10.25208/vdv814 · Cited by 27
Primary sensory neuron-derived miR-let-7b underlies stress-elicited psoriasis
Yang, H., Wang, Y., Chang, W., Zhai, M., Du, W., Jiang, W., Xiang, Y., Qin, G., Yu, J. M., Gong, Y., et al. (2024) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2024.11.005 · Cited by 13
The role and application of three IFN-related reactions in psoriasis
He, J., Zhao, M., Ma, X., Li, D., Kong, J., & Yang, F. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.115603 · Cited by 12
Sorour, N. E., Mustafa, A. I., Alhusseni, N. F., Fawzy, E. M., & Amer, A. G. (2019) · Journal of Cosmetic Dermatology · doi:10.1111/jocd.12937 · Cited by 14
EADV preceptorship: advances in dermatology
Boehncke, W., Katsambas, A. D., Ortonne, J. ‐., & Puig, L. (2010) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/j.1468-3083.2010.03787.x · Cited by 11
Wu, M., & Lee, J. Y. (2011) · Australasian Journal of Dermatology · doi:10.1111/j.1440-0960.2011.00767.x · Cited by 11
“esis of psoriasis, with the former involved in the initiation of the condition(14,15) and the latter involved in both the initiation and maintenance of the lesion.(14,15) In addition, there is evidence for cross-regulation between these two cytokines.”
BackgroundIs ‘class effect’ relevant when assessing the benefit/risk profile of a biologic agent?
Sterry, W., & van de Kerkhof, P. (2012) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/j.1468-3083.2012.04605.x · Cited by 11
Leino, M., Mustonen, A., Mattila, K., Koulu, L. M., & Tuominen, R. J. (2015) · Dermatology and Therapy · doi:10.1007/s13555-015-0076-3 · Cited by 11
“The prevalence of psoriasis is 2–3% worldwide; approximately, 10–30% of patients with psoriasis also have arthritis and nail lesions [1].”
BackgroundTranscription factor AP-1 components as psoriasis candidate genes
Пирузян, Э. С., Nikolskaya, T., Abdeev, R. M., & Brouskin, S. A. (2007) · Molecular Biology · doi:10.1134/s0026893307060143 · Cited by 11
“All of these facts suggest that metabolic processes change, not only in the lesions, but also in the unaffected skin of the same individual and that the unaffected skin of psoriasis patients occupy an intermediate position between the skin of healthy individuals and psoriatic lesions in the set of changed metabolic pr…”
BackgroundChen, W., Ren, G., Zuo, K., & Huang, X. (2018) · Medicine · doi:10.1097/md.0000000000013589 · Cited by 10
“The psoriatic skin lesion is an inflammatory reaction initiated by infiltrating of T cells and neutrophils in epidermis and dermis.([5]) T cells play an important role in the pathogenesis of psoriasis, bone marrow transplantationmayalter the courseof thedisease.”
BackgroundNaldi, L., & Raho, G. (2009) · Expert Opinion on Emerging Drugs · doi:10.1517/14728210902771334 · Cited by 10
“Several hypotheses have been advanced and models proposed over the years concerning the pathogenesis of psoriasis [77-80] .”
BackgroundTOPICAL DELIVERY OF NANOEMULSION FOR ANTIPSORIATIC DRUGS
Khurana, B., Arora, D., & Narang, R. K. (2018) · Journal of Drug Delivery and Therapeutics · doi:10.22270/jddt.v8i5-s.1914 · Cited by 15
Potential therapeutic role of peroxisome proliferator activated receptor-γ agonists in psoriasis
Malhotra, S., Bansal, D., Shafiq, N., Pandhi, P., & Kumar, B. (2005) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.6.9.1455 · Cited by 13
“This has resulted in paradigm shift away from epidermal keratinocytes to various immunocyte populations including T-cell subsets and dendritic APCs to implicate in the pathogenesis of psoriasis [1].”
BackgroundInfluentialForkel, S., Schön, M., Hildmann, A., Claßen, A., John, S. M., Danker, K., & Schön, M. P. (2014) · Journal of Investigative Dermatology · doi:10.1038/jid.2014.170 · Cited by 10
“INTRODUCTION Psoriasis is one of the best-studied inflammatory skin disorders (Nickoloff and Nestle, 2004; Schön and Boehncke, 2005; Griffiths and Barker, 2007; Nestle et al., 2009) and several animal models have helped to understand specific aspects of psoriatic inflammation (Schön, 2008; Wagner et al.”
BackgroundPattern VEP Alterations in Psoriatic Patients may Indicate a Sub Clinic Optic Neuritis
Perossini, M., Turio, E., Perossini, T., Romagnoli, M., Benedetti, S., Cei, G. L., Barachini, P., & Nardi, M. (2005) · Documenta Ophthalmologica · doi:10.1007/s10633-005-4830-1 · Cited by 10
An Overview of the Pathogenesis of Immune-mediated Skin Injury
Danilenko, D. M. (2016) · Toxicologic Pathology · doi:10.1177/0192623316632939 · Cited by 11
“Typical histologic features of psoriasis include epidermal hyperplasia with elongated rete ridges, a less discrete epidermal granular layer (hypogranulosis), parakeratosis, and leukocytic infiltration of the dermis and epidermis (Krueger and Bowcock 2005; Lowes, Bowcock, and Krueger 2007; Nickoloff and Nestle 2004).”
BackgroundO'Daly, J. A., Rodriguez, B., Ovalles, T., & Pelaez, C. (2009) · Archives of Dermatological Research · doi:10.1007/s00403-009-0992-0 · Cited by 10
“que with intraepidermal CD8? T cells and neutrophiles, abundant epidermal thickening, scale production and angiogenesis [18].”
BackgroundDoes HSP90 play an important role in psoriasis?
Czajkowski, R., Kaszewski, S., Tadrowski, T., Grzanka, D., Ziandarska, J., Drewa, G., & Marek‐Józefowicz, L. (2021) · Advances in Dermatology and Allergology · doi:10.5114/ada.2021.106210 · Cited by 9
“Initially, mainly IFN-γ seems to be responsible for the development of psoriatic skin changes [21].”
BackgroundD’Antona, S., Porro, D., Gallivanone, F., & Bertoli, G. R. (2024) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2024.108346 · Cited by 9
Wang, C., Wang, H., Peng, Y., Zeng, B., Zhang, Y., Tang, X., Mi, L., Pan, Y., & Yang, Z. (2020) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/jdv.16725 · Cited by 9
Perfusion Intensity Correlates with Expression Levels of Psoriasis-Related Genes and Proteins
Hendriks, A. G. M., Steenbergen, W., Zeeuwen, P. L. J. M., Schalkwijk, J., Hondebrink, E., Klitsie, M. A. J., Schreurs, R., van de Kerkhof, P. C. M., & Seyger, M. M. B. (2015) · Skin Pharmacology and Physiology · doi:10.1159/000381628 · Cited by 10
Saini, K., Verma, S., & Kakkar, V. (2022) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2022.103301 · Cited by 10
Biologics in the treatment of psoriasis and emerging new therapies in the pipeline
Emer, J. J., Solomon, S. M., & Levy, L. (2012) · Psoriasis Targets and Therapy · doi:10.2147/ptt.s23860 · Cited by 11
“The cell-mediated adaptive immune response is primarily responsible for initiation and maintenance of the disease.(11,12) While T-helper (Th1) cytokines, ie, interferon-gamma (IFN-g), tumor necrosis factor-α (TNF-α), interleukin-2 (IL-2), and IL-12 have long been implicated in the pathogenesis of psoriasis, new resear…”
Psoriasis Care: New and Emerging Pharmacologic Trends
Papp, K. A., & Carey, W. D. (2010) · Journal of Cutaneous Medicine and Surgery · doi:10.2310/7750.2010.09039 · Cited by 9
Retinoid Therapy for Autoimmune Diseases
Fukasawa, H., Kagechika, H., & Shudo, K. (2006) · Japanese Journal of Clinical Immunology · doi:10.2177/jsci.29.114 · Cited by 10
Psoriasis as a disease associated with the immune system disorders
Chomiczewska‐Skóra, D., Trznadel-Grodzka, E., & Rotsztejn, H. (2013) · Central European Journal of Immunology · doi:10.5114/ceji.2013.34370 · Cited by 9
“The clinical manifestations of the disease are different and may include single papules and plaques, larger patches or generalized changes (psoriatic erythroderma) [2].”
BackgroundInfluentialAlataş, E. T., Kalaycı, M. Z., Kara, A., & Doğan, G. (2016) · Dermatologica Sinica · doi:10.1016/j.dsi.2016.08.004 · Cited by 9
Cox, N. H., & Coulson, I. H. (2010) · Wiley eBooks · doi:10.1002/9781444317633.ch5 · Cited by 10
Ayoub, R., Jilani, J. A., Jarrar, Q., Alani, R., Ardianto, C., Goh, K. W., Ali, D. K., & Moshawih, S. (2022) · Molecules · doi:10.3390/molecules27093023 · Cited by 8
“Patients with psoriasis exhibit several skin abnormalities, such as hyperproliferation, atypical keratinocytes, epidermal hyperplasia, inflammation, leukocyte infiltration, and increased vascularity in the skin layers [2,3].”
BackgroundCan nicotine use alleviate symptoms of psoriasis?
Staples, J. A., & Klein, D. M. (2012) · Europe PMC (PubMed Central) · Cited by 8
Dey-Rao, R., & Sinha, A. A. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00640 · Cited by 9
“CS are equally effective in both humoral- and T cell mediated diseases (133).”
BackgroundPhytotherapeutic Potential of Natural Herbal Medicines for Management of Psoriasis: Current Status
Maheshwari, N., Maheshwari, N., Mishra, D. K., & Goyal, A. (2022) · Pharmacognosy Research · doi:10.5530/097484900261 · Cited by 12
Identification of Susceptibility Loci for Skin Disease in a Murine Psoriasis Model
Keß, D., Lindqvist, A.-K., Peters, T., Wang, H., Zamek, J., Nischt, R., Broman, K. W., Blakytny, R., Krieg, T. M., Holmdahl, R., et al. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.7.4612 · Cited by 8
“With a population prevalence of 2%, psoriasis vulgaris is one of the most frequent skin disorders, clinically presenting with thickened erythematous skin covered with silvery scales (7).”
BackgroundPathophysiology of Psoriasis: Current Concepts
Hani, A., & Ghaus, M. (2013) · InTech eBooks · doi:10.5772/54113 · Cited by 8
Anti-Psoriatic Activity of Smilax china Linn. Rhizome
Vijayalakshmi, A., Ravichandiran, V., Velraj, M., Nirmala, S., Male, A., Kumari, J., & Masilamani, K. (2013) · Indian Journal of Pharmaceutical Education and Research · Cited by 8
Higgins, E., Ralph, N., Ryan, S., Koik, N., Honari, B., Lally, A., & Collins, P. M. (2016) · Journal of Dermatological Treatment · doi:10.3109/09546634.2016.1170758 · Cited by 10
“chronic inflammation, with psoriatic T-cell (Th1, Th17)-secreted cytokines contributing to epidermal hyper-proliferation in genetically predisposed individuals (1).”
BackgroundIMMUNOPATHOGENESIS OF PSORIASIS AND PSORIATIC ARTHRITIS AND PHARMACOLOGICAL PERSPECTIVES
Loffredo, S., Ayala, F., Marone, G., Genovese, A., & Marone, G. (2011) · Reumatismo · doi:10.4081/reumatismo.2007.1s.28 · Cited by 8
“Several chemokines (IL8/CXCL8, TARC/CCL17, MIG/CXCL19, IP-10/CXCL10, MDC/CCL22, RANTES/CCL5, MIP-3α /CCL20 and MIP3β/CCL19) and chemokine receptors (CXCR2, CXCR3, CCR4, CCL27-CCR10, and CCR6) found in psoriatic plaques are highly relevant to the pathogenesis of psoriasis, because they promote the migration of bone mar…”
BackgroundGheida, S. F., Neinaa, Y. M. E., & Mohammed, D. A. E.-A. (2018) · Dermatologica Sinica · doi:10.1016/j.dsi.2018.06.002 · Cited by 7
Genome-Wide DNA Methylation and Transcription Analysis in Psoriatic Epidermis
Liu, L., Ju, M., Hu, Y., Luan, C., Zhang, J., & Chen, K. (2023) · Epigenomics · doi:10.2217/epi-2022-0458 · Cited by 7
Garcia, J. P. T., & Tayo, L. L. (2024) · Genes · doi:10.3390/genes15040393 · Cited by 9
Okan, G., Yıldız, Z., Gökdemir, G., Yorulmaz, E., Vural, P., Doğru-Abbasoğlu, S., & Uysal, M. (2015) · Indian Journal of Dermatology · doi:10.4103/0019-5154.152561 · Cited by 7
The Role of Biological Agents in the Treatment of Nail Psoriasis
Zaiac, M. (2010) · American Journal of Clinical Dermatology · doi:10.2165/1153418-s0-000000000-00000 · Cited by 7
Saini, K., Arora, C., Saini, M., Sharma, S., Chitkara, D., & Kakkar, V. (2022) · Food and Chemical Toxicology · doi:10.1016/j.fct.2022.113260 · Cited by 8
The mRNA Expression Profile of Psoriatic Lesion Distinct from Non-Lesion
Li, X., Xing, J., Wang, F., Li, J., Li, J., Hou, R., & Zhang, K. (2022) · Clinical Cosmetic and Investigational Dermatology · doi:10.2147/ccid.s385894 · Cited by 7
Potential future therapies for psoriasis
Papp, K. A. (2005) · Seminars in Cutaneous Medicine and Surgery · doi:10.1016/j.sder.2005.01.005 · Cited by 7
Tian, T., Wei, M., Guan, Y., Rao, L., Luo, T., Han, C., Wei, W., & Ma, Y. (2025) · Cellular Signalling · doi:10.1016/j.cellsig.2025.111706 · Cited by 6
Interface‐Engineered Nanocarriers for Translational and Patient‐Centric Topical Therapy in Psoriasis
Singh, V., Rehman, U., Alqahtani, T., Shmrany, H. A., Gupta, G., Goh, K. W., & Kesharwani, P. (2025) · Drug Development Research · doi:10.1002/ddr.70213 · Cited by 7
A study of ACE, eNOS and MTHFR association with psoriasis in Pakistani population
Agha, Z., Shaiq, P. A., Ahmed, S., Ali, L., Azam, M., Ali, S. H. B., Raja, G. K., & Qamar, R. (2017) · Meta Gene · doi:10.1016/j.mgene.2017.12.001 · Cited by 6
In vivo evaluation of mandibular trabecular and cortical bone quality in psoriasis vulgaris
Günaçar, D. N., Bulut, D. G., Ustaoğlu, G., & Yıldırım, E. A. (2021) · Oral Surgery Oral Medicine Oral Pathology and Oral Radiology · doi:10.1016/j.oooo.2021.12.132 · Cited by 6
Li, J., Hou, R., Yang, Y., Liu, R., Zhao, X., Li, X., Yin, G., An, P., Wang, Y., & Zhang, K. (2013) · Dermatology · doi:10.1159/000346937 · Cited by 6
Sister chromatid exchange analysis in patients with psoriasis
Karaman, A., Aliağaoğlu, C., & Pirim, İ. (2008) · Experimental Dermatology · doi:10.1111/j.1600-0625.2007.00671.x · Cited by 6
Pharmacological Benefits of Herbal Formulations in the Management of Psoriasis vulgaris
Andreea Nicoleta, B. O. C. A., Tataru, A. D., Buzoianu, A. D., Pincelli, C., & Socaciu, C. (2014) · Notulae Botanicae Horti Agrobotanici Cluj-Napoca · doi:10.15835/nbha4219484 · Cited by 6
“Most studies on the immunopathogenesis of psoriasis point to a primary T cell-mediated hyperproliferation of keratinocytes, leading to the well-known lesions (Nickoloff and Nestle, 2004; Homey and Meller, 2008; Jeon et al., 2013).”
BackgroundAssessment of serum interferon-γ in psoriasis
Lashin, S. R., Shoeib, M., Elshafey, E. N., & Sonbol, A. (2015) · Menoufia Medical Journal · doi:10.4103/1110-2098.163907 · Cited by 8
Effect of white mange mixture in a murine model of psoriasis
Guo, J., & Liu, J. (2019) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2019.7641 · Cited by 7
Association between PDCD1 gene polymorphisms and psoriasis susceptibility in the Chinese population
Hua, S., Fan, B., Mao, W., Xu, R., Wang, Y., Kuai, L., Ding, X., Li, B., Chen, J., & Miao, X. (2021) · International Journal of Dermatology · doi:10.1111/ijd.15665 · Cited by 6
Yap, W. H., Cheah, T. Y., Yong, L. C., Chowdhury, S. R., Ng, M. H., Kwan, Z., Kong, C. K., & Goh, B. H. (2021) · Journal of Biosciences · doi:10.1007/s12038-021-00205-y · Cited by 7
Hernández‐Bello, J., Rodríguez‐Puente, M., Gutiérrez‐Cuevas, J., García‐Arellano, S., Muñóz-Valle, J. F., Fafutis‐Morris, M., Villanueva-Quintero, D. G., & Alvarado‐Navarro, A. (2021) · Journal of Clinical Laboratory Analysis · doi:10.1002/jcla.23999 · Cited by 6
Genetic profile of psoriasis patients
Khayrutdinov, V. R., & Khairutdinov, V. R. (2011) · Vestnik dermatologii i venerologii · doi:10.25208/vdv1027 · Cited by 10
“уровень фНО-α коррелирует с активностью псориаза [12, 13].”
Estimation of nitric oxide level in psoriatic patients and its correlation with disease severity
Nada, H., Mahmoud, A., Abo-Elmaged, R., & Fahmy, H. (2013) · Egyptian Journal of Dermatology and Venerology · doi:10.4103/1110-6530.123952 · Cited by 6
Melton, L. P. (2005) · AJN American Journal of Nursing · doi:10.1097/00000446-200503000-00022 · Cited by 6
Netto, E. M., Takahashi, D., de Oliveira, M. D. F. P., Barbosa, P., Ferraz, N., Paixão, A., Oyafuso, L. K. M., Bortoletto, C., Matos, D. C. D. S., Paixão, M. P., et al. (2006) · Vaccine · doi:10.1016/j.vaccine.2006.03.047 · Cited by 6
Safety and Efficacy of Calcium Folinate in Psoriasis: An Observational Study
Carlesimo, M., Mari, E., Arcese, A., Angelis, F. D., Palese, E., Abruzzese, C., Marco, G. D., Cattaruzza, M. S., & CAMPLONE, G. (2010) · International Journal of Immunopathology and Pharmacology · doi:10.1177/039463201002300229 · Cited by 6
“Dermatology II Unit, University of Rome "Sapienza" Via di Grottarossa, 1039 00189 Rome, Italy Tel: ++39 06 33775822 Fax: ++39 06 33775081 e-mail: elenamari4@virgilio.it 649 0394-6320 (2010) Copyright II:! by BIOLIFE.”
Synovial Tissue Response to Treatment in Psoriatic Arthritis
Codullo, V., & McInnes, I. B. (2011) · The Open Rheumatology Journal · doi:10.2174/1874312901105010133 · Cited by 7
“The validation of minimally invasive and repeatable techniques for synovial tissue biopsy has provided a direct insight into the tissue target of the disease.”
Psoriasis Treatments: A Review of the Current Research Pipeline
Golant, A., & Guttman‐Yassky, E. (2011) · Psoriasis Forum · doi:10.1177/247553031117a00102 · Cited by 5
Taqashure Jild: Its similarities and differences with psoriasis
Bhat, M. D. A. (2021) · Clinics in Dermatology · doi:10.1016/j.clindermatol.2021.05.013 · Cited by 5
Lai, B.-C., Xie, X., Li, F., Cui, Q., Dang, E., Luo, W., Wang, N., Zheng, Y., Wang, G., Xiao, L., et al. (2021) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2021.05.017 · Cited by 4
Psoriasis with special reference to Unani medicine – A review
Khatoon, F., Husain, N., Jabeen, A., Uddin, Q., Azahar, M., Qureshi, A., & Khan, A. A. (2022) · Open Health · doi:10.1515/openhe-2022-0024 · Cited by 5
“Hippocrates (460–377 BCE), the “father of medicine” coined the term psora, which literally means “itch” [20].”
BackgroundAlzahrani, S., Alzamil, F. M., Aljuhni, A., Thaqfan, N. A. A., Alqahtani, N. Y., Alwarwari, S. A., Alkharashi, A. A., Alzabadin, R. A., Alzehairi, R. A., & Alhajlah, A. (2023) · Cureus · doi:10.7759/cureus.50588 · Cited by 6
“Psoriasis’s precise etiology remains uncertain; nevertheless, it is hypothesized to be the result of an intricate interplay between environmental and genetic influences [4,5].”
BackgroundAngelis, R. D., Gasparini, S., Bugatti, L., & Filosa, G. (2005) · Dermatology · doi:10.1159/000083519 · Cited by 5
Tripo, L. (2013) · Journal of Clinical & Experimental Dermatology Research · doi:10.4172/2155-9554.1000165 · Cited by 5
“European J of Inflammation 9: 277-284.”
BackgroundFunctional study of TNF-α as a promoter of polymorphisms in psoriasis
DAPRÀ, V., PONTI, R., CURCIO, G. L., ARCHETTI, M., Maddalena, D. I. N. I., GAVATORTA, M., QUAGLINO, P., FIERRO, M. T., & BERGALLO, M. (2022) · Italian Journal of Dermatology and Venereology · doi:10.23736/s2784-8671.21.06979-0 · Cited by 5
Deigin, V. I., Linkova, N. S., Vinogradova, J., Vinogradov, D. S., Polyakova, V. O., Медведев, Д. С., Krasichkov, A. S., & Volpina, O. M. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25095042 · Cited by 4
“They were localized within the inflammatory infiltrate and stratified squamous epithelium [98].”
BackgroundFatani, M. I. A., Binamer, Y., Almudaiheem, H., Eshmawi, M. T., Aljehani, F., Alshammari, S., & Al-Jedai, A. H. (2025) · Dermatology and Therapy · doi:10.1007/s13555-025-01436-9 · Cited by 6
“Psoriasis is a chronic inflammatory skin disor‑ der that affects approximately 2% to 3% world‑ wide [1, 2].”
Psoriasisli Hastalarda İşitme Kaybının Değerlendirilmesi
Güvenç, S. C., Turan, H., Yilmaz, S. H., Yanık, M. E., Berada, A., & Aliağaoğlu, C. (2012) · TURKDERM · doi:10.4274/turkderm.15986 · Cited by 4
Lok, K. (2007) · World Journal of Gastroenterology · doi:10.3748/wjg.v13.i29.4022 · Cited by 4
“Similarly, the pathogenesis of psoriasis is also attributed to the immune dysregulation by T-lymphocytes [ 18 ]”
BackgroundHou, M., Xing, H., Cai, Y., Wang, X., Xie, Z., Zhang, Q., Ma, Y., & Chen, J. (2019) · European Journal of Dermatology · doi:10.1684/ejd.2019.3553 · Cited by 4
El‐Kalioby, M., El-Komy, M. H. M., Said, E. R., Amer, M. A., Saadi, D. G., Mohammed, F. N., Rashed, L. A., Desouky, E. D. E., & AlOrbani, A. M. (2021) · Journal of Dermatological Treatment · doi:10.1080/09546634.2021.1967265 · Cited by 4
“inflammation, and neovascularization (3,4).”
Promises and limitations of targeting adhesion molecules for therapy
Yonekawa, K. E., & Harlan, J. M. (2007) · Birkhäuser Basel eBooks · doi:10.1007/978-3-7643-7975-9_13 · Cited by 4
“Psoriasis is theorized to be the result of keratinocyte stimulation and subsequent dendritic and T cell activation [ 38 ].”
Background
Metadata
- Authors
- Nickoloff, B. J., & Nestle, F. O.
- Affiliations
- Loyola University Medical Center (US)
- University of Zurich (CH)
- Corresponding author
- Nickoloff, Brian J.
- Venue
- Journal of Clinical Investigation
- Published
- 2004-06-15
- Volume
- 113
- Issue
- 12
- Pages
- 1664-1675
- ISSN
- 0021-9738 (ISSN-L)
- PMC
- PMC420513
- OpenAlex
- W2024387258
- Cited by
- 544
- References
- 110
- Citations by year
- 2026: 4 · 2025: 8 · 2024: 9 · 2023: 11 · 2022: 23 · 2021: 18 · 2020: 10 · 2019: 23 · 2018: 18 · 2017: 17 · 2016: 19 · 2015: 24 · 2014: 26 · 2013: 29 · 2012: 27
- FWCI
- 19.28
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Clinical Investigation (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Research Portal (King's College London) (submittedVersion)
- Funders
- Doris Duke Charitable Foundation
- National Institute of Arthritis and Musculoskeletal and Skin Diseases (R01 AR40065, R01AR040065)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Psoriasis: Treatment and Pathogenesis
- Health Sciences › Medicine › Dermatology › Dermatology and Skin Diseases
- Health Sciences › Medicine › Rheumatology › Spondyloarthritis Studies and Treatments
- Keywords
- psoriasis, immunopathogenesis, T cells, immunological synapse, cytokine signaling pathways, xenotransplantation model, targeted therapy, psoriasis genetics, chronic skin inflammation, psoriatic arthritis
- MeSH terms
- Animals, Dermatologic Agents, Disease Models, Animal, Disease Susceptibility, Humans, Immune System, Psoriasis, T-Lymphocytes, Signal Transduction
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.